Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease

Chihiro Udagawa, Hidehito Horinouchi, Kouya Shiraishi, Takashi Kohno, Takuji Okusaka, Hideki Ueno, Kenji Tamura, Yuichiro Ohe and Hitoshi Zembutsu

PLOS ONE, 2019, vol. 14, issue 10, 1-13

Abstract: Drug-induced interstitial lung disease (DIILD) is a serious side effect of chemotherapy in cancer patients with an extremely high mortality rate. In this study, to identify genetic variants with greater risk of DIILD, we carried out whole genome sequencing (WGS) of germline DNA samples from 26 patients who developed DIILD, and conducted a case-control association study between these 26 cases and general Japanese population controls registered in the integrative Japanese Genome Variation Database (iJGVD) as a screening study. The associations of 42 single nucleotide variants (SNVs) showing P

Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0223371 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 23371&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0223371

DOI: 10.1371/journal.pone.0223371

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().